Smith & Nephew plc SN.

Investing.com -- Goldman Sachs added Solaria, Straumann, Scout24 and IMCD to its European Conviction List for October, while removing Naturgy, Norsk Hydro and Smith & Nephew, the broker said in a note dated Thursday.

SNN expands its trauma portfolio with the EVOS PELVIC System, targeting complex pelvic and acetabular fracture procedures in the United States.

Dublin, Sept. 28, 2026 (GLOBE NEWSWIRE) -- "Sports Rehabilitation Equipment Market Global Report 2026" has been added to ResearchAndMarkets.com's offering. The global sports rehabilitation equipment market is experiencing strong growth, driven by the rising incidence of sports injuries, expanding physiotherapy services and increasing awareness of rehabilitation therapies. The market is projected to grow from $4.39 billion in 2025 to $4.79 billion in 2026, representing a compound annual growth ra

The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address the unique challenges of pelvic and acetabular surgery. EVOS PELVIC System is built on the proven principles of the EVOS platform that has become a trusted choice for traum

The All-in-one system combines plates, cannulated screws and specialized instrumentation to streamline complex pelvic surgery Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the launch of the EVOS PELVIC Plating System, the next evolution of the EVOS plating platform designed to address the unique challenges of pelvic and acetabular surgery. EVOS PELVIC System is built on the proven principles of the EVOS platform that has become a trusted choice for traum

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and has completed the first surgical cases with LANDMARK Total Knee System, a next-generation knee replacement solution designed to replicate healthy knee anatomy and the knee’s natural motion and support a more personalized approach to total knee arthroplasty.As expectations for total knee arthroplasty continue to evolve, surgeons

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will highlight a suite of advanced solutions for shoulder repair and reconstruction at the International Congress for Shoulder and Elbow Surgery (ICSES) in Vancouver from September 22-25. Surgeons are invited to visit the Smith+Nephew booth during ICSES to learn more about the following technologies: TENDON SEAM Rotator Cuff Repair SystemRecently acquired by Smith+Nephew, the TENDON SEAM System is a unique

The latest analyst work on S.N. Nuclearelectrica centers on a revised price target of RON 49.75, up from RON 44.80. This sets a new reference point for how the stock is being valued. This change reflects a mix of optimism and caution in recent commentary, with research tying the new target to refreshed assumptions rather than a single event. As you read on, you will see how this evolving narrative might shape the way you track S.N. Nuclearelectrica from here. Stay updated as the Fair Value...

Smith+Nephew announces results of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, GB / ACCESS Newswire / September 16, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announced today the results of its previously announced offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to

Smith+Nephew announces pricing of its cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, UK / ACCESS Newswire / September 15, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announced today the pricing of its previously announced offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to

Reducing headcount at the Swiss site is part of an ongoing effort to simplify the company’s manufacturing footprint and supply chain.

Smith+Nephew announces cash tender offer for up to $250 million of its outstanding 2.032% notes due 2030LONDON, UK / ACCESS Newswire / September 8, 2026 / Smith+Nephew, the global medical technology company (the "Company") (LSE:SN)(NYSE:SNN), announces today an offer to purchase for cash (the "Tender Offer"), upon the terms and subject to the conditions set forth in an offer to purchase dated September 8, 2026 (the "Offer to Purchase"), up to U.

The fair value estimate for S.N. Nuclearelectrica has shifted from RON 49.0 to RON 44.8, which signals a more cautious price target in current analyst models. This adjustment aligns with recent commentary that connects the lower target to a reassessment of the stock’s risk and reward profile. As you read on, you will see how to interpret these changes and monitor the evolving narrative around S.N. Nuclearelectrica. Stay updated as the Fair Value for S.N. Nuclearelectrica shifts by adding it...

John Rogers, who has experience leading change at companies, is expected to help Baxter’s turnaround gain traction. He joins Baxter after the company sold two business units.

Smith+Nephew's five-year Imperial College London partnership targets less invasive robotic surgery and could speed research into clinical use.

8.44am: Inflation may not move Bank of England dial Some thoughts on this morning's UK inflation numbers, which showed July's CPI up 2.9% from a year ago, increasing from 2.6% in June. Core CPI stayed put at 2.6%, while services CPI slowed to 3.4% from 3.6%. "What happened in July?...

SNN launches the FLOW FLEXTEND COBLATION Wand, offering adjustable-angle access and precise tissue removal in complex joint procedures.

Marking a new approach to innovation in medical robotics, the new centre will bring advances from a leading surgical robotics research group to patients more quickly Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, and Imperial College London have launched a five-year partnership to deliver breakthrough research and innovation for robotic surgery for musculoskeletal conditions. The first-in-kind partnership will bring together a globally renowned academic laboratory with e

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces a breakthrough in RF resection technology for hip with its new FLOW FLEXTEND COBLATION Wand. Designed as an extension of its proprietary FLOW~IQ◊ technology with an adjustable-angle tip, the FLOW FLEXTEND Wand is designed to give surgeons enhanced joint access1* and precise tissue targeting3 for hard-to-reach hip, knee and shoulder anatomies. Determining the root cause of a patient’s hip pain can be very chal

Moby summary of Spectral AI, Inc.'s Q2 2026 earnings call